Henry Schein, a distributor of healthcare products and services, has been named Formlabs' preferred North American reseller.

Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

MELVILLE, N.Y., February 12, 2025--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

Exhibit B includes a reconciliation of preliminary GAAP net income to preliminary Adjusted EBITDA. Henry Schein also today announced preliminary financial guidance for 2025. Revenues and non-GAAP ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...

Patients at the Lyell McEwin Hospital were less likely to be re-admitted when their likelihood of discharge was evaluated by ...